Why is Bliss GVS Pharma falling/rising?

As of 19-Sep, Bliss GVS Pharma Ltd's stock price is currently at 150.40, reflecting a decrease of 3.35, or 2.18%. The stock has underperformed its sector today by 2.45% and has experienced a trend reversal, falling after two consecutive days of gains. It reached an intraday low of Rs 150.35. Over the past week, the stock has declined by 1.34%, and in the last month, it has dropped 13.14%. Despite generating a return of 20.80% over the past year, the company's profits have decreased by 3.6%. The stock is trading at a premium compared to its peers, and while it has a low debt-to-equity ratio and consistent returns over the last three years, these factors have not prevented the recent decline.
Broader market context indicates that the Sensex has increased by 0.88% over the past week, contrasting with Bliss GVS Pharma's decline. The stock's year-to-date performance shows a drop of 8.65%, while the Sensex has gained 5.74%. This underperformance relative to the benchmark suggests that investor sentiment may be negatively impacted by the company's recent profit decline and premium valuation, despite its historical performance. The rising investor participation, indicated by an increase in delivery volume, may not be sufficient to counteract the stock's current downward trend.